Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Nature cell biology | Aug 8, 1999

http://www.ncbi.nlm.nih.gov/pubmed/10559916

Degradation of the mammalian cyclin-dependent kinase (CDK) inhibitor p27 is required for the cellular transition from quiescence to the proliferative state. The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin-CDK complexes. However, the ubiquitin-protein ligase necessary for p27 ubiquitination has not been identified. Here we show that the F-box protein SKP2 specifically recognizes p27 in a phosphorylation-dependent manner that is characteristic of an F-box-protein-substrate interaction. Furthermore, both in vivo and in vitro, SKP2 is a rate-limiting component of the machinery that ubiquitinates and degrades phosphorylated p27. Thus, p27 degradation is subject to dual control by the accumulation of both SKP2 and cyclins following mitogenic stimulation.

Pubmed ID: 10559916 RIS Download

Mesh terms: Base Sequence | Cell Cycle Proteins | Cell Line | Cyclin-Dependent Kinase Inhibitor p27 | Cyclin-Dependent Kinases | Enzyme Inhibitors | HeLa Cells | Humans | In Vitro Techniques | Kinetics | Microtubule-Associated Proteins | Oligodeoxyribonucleotides, Antisense | Phosphorylation | Protein Binding | RNA, Messenger | S-Phase Kinase-Associated Proteins | Tumor Suppressor Proteins | Ubiquitins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: R01 CA76584
  • Agency: NIGMS NIH HHS, Id: R01 GM57587

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.